Deutsche Bank Offers Quick Thoughts On Teva Pharmaceutical's Generic Nexium By: Benzinga via Benzinga January 27, 2015 at 09:33 AM EST In a report published Tuesday, Deutsche Bank analyst Gregg Gilbert reiterated a Buy rating and $65.00 price target on Teva ... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR